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HEPATITIS B AND C: AN ASSESSMENT OF RISK EXPOSURE AND PREVALENCE 
AMONG PRECLINICAL MEDICAL STUDENTS IN NORTHWESTERN NIGERIA.
ABSTRACT
Background
The risk of transmission of hepatitis B and C (HBV and HCV) infection is of particular concern among medical students training 
in high endemic regions. In this study,we investigated the risk and prevalence of hepatitis B and C viruses among preclinical 
medical students in a government-owned medical school in northwestern Nigeria.
Methods
We employed a cross-sectional studytargeting the whole population of preclinical medical students of Kaduna State 
University, Kaduna State northwestern Nigeria. Data were collected usinga self-administered, semi-structured 
questionnaire and blood testing for HBsAg and HCV antibodies using rapid screening kits.Data were analyzed using SPSS 
version 22.
Results
A total of 133 students participated, and 79.7% of them had a previous risk exposure to injuries by sharps. The 
seroprevalence for HBV and HCV was 0.8% for both infections. Complete HBV vaccination uptake (3 doses)before enrolment 
in medical school was 18.8%. The knowledge that HBV infection is preventable was a significant determinant for the previous 
testing for hepatitis B and C.
Conclusion
Risk exposure to injuries by sharps was high in preclinical students. But their seroprevalence for both hepatitis B and C were 
low. 
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epatitis B and C viruses (HBV and HCV) cause 
infections that affect the liver. Worldwide HBV is 
the most common cause of chronic liver H
1, disease,including cirrhosis and hepatocellular cancer.
2Globally, there are about 2 billion people infected with 
HBV and an estimated 360 million with chronic infections. 
Annually, the disease also accounts for the death of about 1 
3, 4million people.  Nigeria is one of the countries in which 
HBV is highly endemic with an estimated 12% of the 
population beingchronic carriers, although studies among 
5,6selected populations report varying prevalence rates.  
HBV is spread between people usually through contact 
with the blood or other body fluids of infected persons, 
among other modes of transmission.Healthcare workers 
and medical students are at risks of infection through 
7, 8occupational exposure to blood and body fluids.
HCV remains a large healthcare burden to the world, and it 
has been estimated to have a worldwide prevalence of 
about 3% with the virus affecting about 170 million 
9people.  The prevalence of HCV infection is greatest in the 
low-income countries of sub-Saharan Africa and south-
east Asia, where about 8-10% of the population are chronic 
carriers. The disease is transmitted primarily through 
parenteral exposure (bloodborne).Sexual transmission 
almost certainly occurs, but its public health importance is 
not well quantified. HCV-infected persons can remain 
asymptomatic for many years following initial infection; 
however, the virus is a major cause of acute hepatitis and 
chronic liver disease; including cirrhosis, liver cancer and 
decompensated liver failure.
Medical students are at a high risk of acquiring blood-
borne infections including HBV and HCV, as, during the 
course of their clinical work, they are in direct contact with 
patients, blood, injections and surgical instruments. They 
are also at risk ofworkplaceaccidents that occur during the 
period of their practical training. The lack of professional 
skillsand experience on the part of the students increases 
their risk exposure in the course of invasive medical 
procedures. Previous studies have shown that medical and 
para-medical studentslack adequate knowledge about 
10-13hepatitis B and C.  Other studies showed prevalence 
ranges of between 4.2 to 12.5% for HBV and 1.5 to 3.6% for 
HCVand a vaccination rate of 19.2% for hepatitis B 
14-17amongst medical students. Vaccination is the best means 
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by which one can arm oneself against hepatitis B infection. 
The transmission rate is as high as 30% in those who are not 
18immune but rare in those who have been immunized.
Medical students come into contact with patients 
immediately they commence the clinical phase ofmedical 
school. It is relevant that sufficient considerationbe given 
to prevention measures like vaccination and health 
education. These measures will be most effective if it 
targets the medical students prior to their first contact with 
patients.The vaccination against hepatitis B is 
recommended to minimize the risk of this occupational 
infection. Although the exposure to the clinical 
environment of the hospital will increase the risk of 
exposure to bloodborne viral hepatitis for medical 
students, the availability of information about their 
seroprevalence status during the preclinical phase of their 
training will provide evidence for the appropriate timing 
for the hepatitis B vaccination. Therefore, the objective of 
this study was to determine the prevalence and risk 
exposure of hepatitis B and C virus infections of pre-




A cross-sectional study was conducted between January-
March 2013 among pre-clinical, medical students of 
Kaduna State University (KASU), Kaduna, Nigeria.
Study Location and Population
Kaduna State University is sited in Kaduna, which is the 
capital of Kaduna State, located in northwestern Nigeria. 
The medical school of this universitywas established in 
2007 with an initial intake of 46 students in 2009. At the 
time of conducting the study in 2013, the number of 
students had grown to 148, distributed acrossthree levels 
of study. The study population included all registered pre-
clinical)medical students of the university. 
Sampling Method
A whole population sampling method was used for the 
study, and all medical (pre-clinical) students of the 
university who were duly registered at the time of the 
study and gave informed consent were included in the 
study. Thus, a total sample population of 133 
respondents(representing 89.9% of the student 
population) participated in the study.
Data collection
A self-administered, semi-structured questionnaire was 
used to collect information about: 1) Respondents' socio-
demographic characteristics including age, gender, year of 
study in medical school, previous enrolment in other 
medical school(s)and previous employment as a health 
worker.2) Previous risk exposure with regard to sharp 
injuries, including needles.3) Previous testing and 
outcome for hepatitis B and Hepatitis C. 
Before commencement of data collection members of the 
research team composed of threepublic health physicians 
and two laboratory scientists were trainedon the 
questionnaire and its mode of administration. The 
principal investigator supervised the overall data 
collection activities.Informed consent was obtained from 
all medical students that consented, but three students 
completed the questionnaire but declined to have their 
blood samples taken for undisclosed reasons. The 
questionnaire administration and taking of blood samples 
were done during afternoon breaks on consecutive days 
until all the students that consented were reached. Blood 
samples for testing were obtained from participants 
through a finger prick with a lancet under sterile 
conditions. Thereafter, laboratory testing for hepatitis B 
and C viral infections was performed on the samples.  
Laboratory Testing:
For the diagnosis of hepatitis B virus and hepatitis C 
virus infections,finger prick specimens of whole blood 
were obtained from the participants with a lancet after 
cleaning the area to be lanced with an alcohol swab.Testing 
of each participant's whole blood sample for HBsAg and 
HCV antibodies were done using Micro-point HBsAg and 
HCV antibodies Gold Rapid Screening kits according to 
the manufacturer's instruction. Each test kit is a 
chromatographic immunoassay (CIA) for the direct 
qualitative detection of HBsAg and HCV antibodies. 
Similar rapid screening tests were also used in a study to 
assess the prevalence of hepatitis C in Makurdi, north-
central Nigeriaand the prevalence of hepatitis B and C and 
19,20co-infection with HIV in Malawi.
Data Analysis:
The questionnaires were checked for completeness and 
consistency. Data were entered into data entry templates 
and analyzed usingStatistical Package for Social Sciences 
(SPSS), version 23.0 (IBM Corp., New York, USA). Main 
outcome variable was hepatitis B and hepatitis C 
serostatus while the independent variables were socio-
demographic characteristics and risk factors for hepatitis B 
and C. Descriptive statistics such as mean and standard 
deviation were generated for variables including 
frequencies and percentages for categorical variables. 
2Bivariate analysis was carried out, and the Chi-square (x ) 
test was used to test associations between variables.  A p-
value of less than 0.05 was used as the cut off level for 
statistical significance
Ethical Considerations:
The Ethics Research Committee of the Kaduna State 
Ministry of Health approved the research protocol. 
Permission was also obtained from the management of the 
Kaduna State University prior to conducting this 
study.Written informed consent was obtained from all 
studentsthat consented to participate. 
. Subsequently, administration of 
hepatitis B vaccine to HBV-negative individuals was done. 
Those who tested positive were linked with the health care 
system for further management. 
.
Confidentialitywas 
assured for all information provided and for the results of 
the investigations
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Results 
A total of 133 preclinical students participated in the study. 
This consists of 85 (63.9%) males and 48 (36.1%) females. 
Risk exposure and awareness of the consequences of the 
same were over 75% among participants (Table 1). Only 
30.5% of the respondents were previously tested for HBV, 
out of which 2 (5.0%) tested positive for HBV. The 
prevalence of those that previously tested for HCV was 
33.6% andthe seropositivityof 4.5% (Table 2). Only one 
respondent tested positive for each antigen (with a 
seroprevalence of 0.8% for each antigen) during current 
testing; the majority of participants (96.2%) tested negative 
for both HBV and HCV. Almost one-third (29.0%) of the 
participants had previously been vaccinated against HBV, 
65.8% of whom had received 3 doses of the vaccine; while 
the majority of same (73.7%) had a fairly recent (<5 years) 
history of HBV vaccination.
Among the evaluated socio-demographic factors, only 
knowledge that viral hepatitis is preventable is positively 
associated with the previous testing of both hepatitis Band 
C (Table 3). Meanwhile, gender, age, year of study in 
medical school, previous enrolment in medical school or 
employment as a health worker, and knowledge of 
hepatitis being preventable of the medical student were 
not associated with previous vaccination against hepatitis 
B (Table 4).
Discussion
The health risks associated with patient care are a 
recognized occupational hazard in medical and 
paramedical professions globally; as accidental 
transmissions of infectious diseases have been reported in 
21developing and developed countries. The developing 
countries are of particular concern because over 90% 
ofsuchoccupational exposures among health workers 
22occur in this setting.  Fundamentally, the risk of these 
occupational mishaps have been observed to bemore 
among novices in the profession such as students, interns 
12and other categories of trainess .This has been attributed 
to several factors such as inadequate knowledge, lack of 
experience and professional expertise, fatigue, stress, 
anxiety, lack of supervision and tutorial support from 
11-12, 22older professionals etc.
Invasive medical procedures involving the use of sharp 
instruments particularly with ungloved hands exposes 
healthcare workers and students to the blood and other 
body fluids of patients, which may be infectious in 
7,23-24,25nature. These exposures increasethe risk of blood-
26borne infectionslike hepatitis B and C viruses. Our study 
finding indicates ahigh prevalence of previous risk 
exposure due to injury by sharps among pre-clinical 
medical students. This is plausible considering the 
common use of sharp objects for personal (shaving, 
barbing and nail cutting), domestic and occupational 
purposes as well as cultural practices like scarification 
marks in the study setting. However, our result contrasts 
with lower prevalenceas reported in otherstudies 
conducted among medical students as well as students and 
interns of other paramedical and health-related 
28-31professions in developingcountries, including Nigeria.  
A much lower prevalence has been in the same category of 
32,33students indeveloped nations. Generally, developing 
countries have prevalence level similar to the global 
prevalence of needle stick injuries among medical 
34students, which is lower than our finding.  Nevertheless, 
exceptionallyhigher prevalence has been reportedin some 
22,35developing nations.
It is remarkable that only a negligible number of the 
participants of this study had either been enrolled in a 
medical school or served as health workers in the 
past.Hence, the high prevalence of previous exposure to 
injury by sharps obtained in this study is rather alarming 
for preclinical students because most needle stick injuries 
have been documented to occur during clinical 
36training. Further investigation will be required to assess 
the risk exposure to sharp injuries in pre-clinical years, 
particularly during anatomy dissection session or 
Physiology practical classes. This will provide evidence 
about the suitability of instituting pre-exposure 
prophylactic vaccination for medical studentsat the onset 
of medical school rather than wait untilthe beginning of 
30clinical training.
The knowledge of the potential dangers and risks posed by 
such injuries by sharps, including needles for infection 
with hepatitis B and C was high among our study 
participants. This finding compares with studies among 
28 17medical students in other parts of Nigeria. , On the 
contrary, there are studies that showed limited or 
inadequate knowledge regarding sharps injuries among 
medical and dental students in Scotland and 
32,37India. Precisely, a lack of awareness among medical 
students entering into the profession and a significant 
difference between knowledge of pre-clinical and clinical 
11,13students has been observed. In spite of this relatively 
good level of awareness among the cited Nigerian 
studies,the continuous teaching and training of medical 
students on the risks and hazards associated with injuries 
with sharps. Additionally, the measures to be taken to 
avert them as well as manage them in the event of their 
occurrence should be encouraged as the mainstay of 
prevention of occupationally-acquired infections.
An estimated hepatitis B seroprevalence of one-tenth the 
adult population has been reported for sub-Saharan 
27Africa, including Nigeria. Thus, the laboratory testing to 
ascertain the hepatitis B and Cstatus of individuals is key to 
prevention and control of viral hepatitis. In this study, only 
one-third of the participants had previously been tested for 
both hepatitis B and C. This low proportionof those that 
hadpreviously tested for hepatitis B and C among the 
participants may be a reflection of the poor practice of 
routine or voluntary medical examinations in developing 
38countries. Our finding corroborates other Nigerian 
studies for low previous testing of hepatitis B and C even 
though a higher proportion had been screened for HIV at 
39least once.
The voluntary submission to routine medical 
examinations is uncommon among Nigerians as well as 
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nationals of many other developing nations. In this study, 
the knowledge that hepatitis B is a preventable disease was 
significantly associated withthe previous testing for 
hepatitis B and C. Contrary to expectation the of 
proportion those that had previously tested for hepatitis C 
were more than for hepatitis B. Generally,there is a higher 
level of awareness and knowledge in the larger population, 
40of HBV infection as a disease entity, as compared to HCV.  
Likewise, the World Health Organization reports that 
prevalence data and studies on HBV abound as compared 
with HCV, which has a relative paucity of information in 
circulation; and therefore, a lower level of awareness and 
9understanding in the general population.  Furthermore; 
this situation is also reported to have engendered some 
confusion between HBV and HCV within certain 
41populations.  This might have contributed to the resultant 
outcome reflected in this study.
Majority of ourstudy participants had a negative outcome 
for current testing, with only a participant that tested 
positive for either hepatitis B or C.It is documented that 
with a seroprevalence of over 10% reported from various 
studies and surveys,Nigeria is classified as a high endemic 
5,6,42,43region.  The seroprevalence for HBV obtained in this 
studyis extremely lower than that reported by various 
authors working among undergraduate students in 
15,44-47different parts of Nigeria. The low seroprevalence we 
found may be due to the fact that the entire study 
population are pre-clinical students, who are yet to 
commence direct interactions with patients or the clinical 
environment with its attendant risks. 
Pre and immediate post-exposure prophylactic 
vaccination with hepatitis B vaccine are globally 
recognized and advocated measures for the prevention 
and control of HBV infection.In this study, only about one-
third of the participants had previously been vaccinated 
against HBV, and only 66% of them had received the 
48recommended 3 doses of the vaccine.  The observed 
inadequateor sub-optimalvaccination is comparable with 
studies among medical students in Nigeria and other parts 
1 7 , 3 0 , 2 8 , 4 9o f  s u b - S a h a r a n  A f r i c a T h e s e  s a m p l e d  
studiesreported values lower thanamong medical 
7,8students and personnelindeveloped countries.  In the 
United States, for instance, the Centre for Disease Control 
and Prevention (CDC) has since set a goal of achieving 98% 
hepatitis B vaccination coverage among health workers, 
with the intention of eliminating occupationally-acquired 
50HBV infection in that country. Therefore, the goal of 
forestalling the huge morbidity and mortality 
consequences on human resource for health should be 
enhanced by advocacy for pre-exposure vaccination and 
instituted as mandatory for all medical students and 
personnel. 
Finally,the majority of our participants had recent (1-4 
years) history of HBV vaccination,which corresponded 
with the period of their admission to medical school. 
Whether this is merely a coincidence or an initiative taken 
up by these respondents as a prophylactic measure, in 
view of their enrollment into medical school was not 
further explored becauseof its non-inclusion in the scope of 
this study. Personal motivation could explain this 
behaviour, but none of the socio-demographic factors was 
found to significantly determine previous vaccination 
against HBV. The knowledge that HBV is preventable was 
positively associated withprevious testing for the disease 
and not for vaccination. Thismight suggest other barriersto 
HBV vaccine uptake among medical students. These 
factors includelimited or no opportunity, lack of time 
(busy or tight schedule), financial constraints (out-of-
pocket expenses either for the vaccine or the consumables 
used, or both), information gaps (such as not aware a 
vaccine exists, fears and concerns regarding possible 
vacc ine  s ide  e f fec t s  e t c . ) ,  ind i f fe rence  and  
28,30procrastination.  As valid and genuine as some of these 
factors might be, all efforts need to be put in place to ensure 
higher HBV vaccine uptakes for medical students and 
health care workers in moderate to high endemic areas.
Conclusion 
The risk exposure to injuries by sharps, including 
needlestick,was observed to behigh among preclinical 
students. Fortunately, the seroprevalences recorded for 
both hepatitis B and C were low. However, the low 
hepatitis B vaccine uptake in the context ofa high endemic 
adult population constitutes a major public health 
problem. Consequently, we recommend regular training 
on universal precaution and hepatitis B vaccination early 
in medical training.
Table 1: Previous exposure and testing for hepatitis B and C viruses among preclinical medical students 
Variable Frequency (%) 
Previous needle or sharp injury 106 (80.9) 
Aware of the consequences of sharp injuries 102 (77.9) 
Previously tested for hepatitis B 40 (30.5) 
Previously tested positive for hepatitis B 2 (5.0) 
Previously tested for hepatitis C 44 (33.6) 
Previously tested positive for hepatitis C 2 (4.5) 
Tested positive for only HBV in current testing* 1 (0.8) 
Tested positive for only HCV in current testing 1 (0.8) 
Tested positive for both HBV and HCV in current test 0 
*Declined consent for current testing=3 (2.3%); Some variables have missing records
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Table 2. Prevalence of previous vaccination against hepatitis B virus among preclinical medical students 
Variable Frequency (%) 
Previously vaccinated (n=131) 
Yes 38 (29.0) 
Number of Doses Given (n=38) 
1 4 (10.5) 
2 9 (23.7) 
3 25 (65.8) 
Time interval since previous vaccination in years (n = 38) 
1-2 8 (21.1) 
3-4 20 (52.6) 
≥5 10 (26.3) 
Some variables have missing records 
Table 3: Association between socio-demographic characteristics and previous testing for hepatitis B and C  viruses among 
preclinical medical students  
Characteristic (n=131)


















26 (65.0) 60 (65.9) 33 (75.0) 53 (60.9)
Age in years 
    
<20
 





23 (57.5) 63 (70.0) 25 (56.8) 61 (70.9)
≥25
 




















3rd 15 (37.5) 26 (28.6) 11 (25.0) 30 (34.5)
4th
 
5 (12.5) 19 (20.9) 7 (15.9) 17 (19.5)
 












(3.3) 0.262* 3 (6.8) 3 (3.4)
 
0.322*










0.485* 2 (4.5) 3 (3.4) 0.547*
Knowledge of hepatitis B is 
preventable 
 
Yes 36 (90.0) 33 (36.3) 0.003* 40 (11.8) 54 (62.1) <0.05*
*Fischer’s exact test; Some variables have missing records
Table 4: Association between socio-demographic characteristics and previous vaccination against Hepatitis B among 
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26 (68.4) 60 (64.5)














































3 (7.9) 3 (3.2) 0.246*
Previous employment as health 
worker
 
   
Yes
 
2 (5.3) 3 (3.2) 0.581
Knowledge of hepatitis B is 
preventable  
   
Yes 33 (86.8) 61 (65.6) 0.014* 
*Fischer’s exact test; Some variables have missing records
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